Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in LEGN — Legend Biotech Corp

CIK 1423053 MIAMI, FL
Back to LEGN Full portfolio

Position in LEGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$985,992
-$8,366,175 QoQ
Shares Held
34,141
-93.4% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 218 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LEGN Over Time

Shares Held

Position Value (USD)

Derivatives in LEGN

reported options exposure · as of Jun 30, 2026
CallValue
$3,347,192
CallShares
115,900
PutValue
$4,011,432
PutShares
138,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. LEGN ranks #231 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in LEGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,347,192 115,900
2026-06-30 $985,992 34,141
2026-06-30 $4,011,432 138,900
2026-03-31 $1,742,067 96,300
2026-03-31 $1,179,468 65,200
2026-03-31 $9,352,167 516,980
2025-12-31 $3,870,589 178,040
2025-12-31 $1,547,888 71,200
2025-12-31 $1,380,490 63,500
2025-09-30 $1,206,570 37,000
2025-09-30 $12,483,499 382,812
2025-09-30 $1,500,060 46,000
2025-06-30 $5,858,014 165,061
2025-06-30 $1,550,913 43,700
2025-06-30 $1,412,502 39,800
2025-03-31 $953,433 28,100
2025-03-31 $600,561 17,700
2025-03-31 $5,265,053 155,174
2024-12-31 $914,374 28,100
2024-12-31 $94,524,046 2,904,857
2024-12-31 $1,002,232 30,800
2024-09-30 $64,155,675 1,316,554
2024-09-30 $989,219 20,300
2024-09-30 $1,427,789 29,300
2024-06-30 $63,992,981 1,444,863
2024-06-30 $974,380 22,000
2024-06-30 $1,638,730 37,000
2024-03-31 $5,479,993 97,700
2024-03-31 $64,193,658 1,144,476
2024-03-31 $4,509,636 80,400
2023-12-31 $2,948,330 49,000
2023-12-31 $9,984,068 165,931
2023-12-31 $1,089,077 18,100
2023-09-30 $517,209 7,700
2023-09-30 $1,441,132 21,455
2023-09-30 $806,040 12,000
2023-06-30 $566,046 8,200
2023-06-30 $303,732 4,400
2023-06-30 $2,679,192 38,812
2023-03-31 $1,210,322 25,100
2023-03-31 $270,032 5,600
2023-03-31 $352,054 7,301
2022-12-31 $2,346,240 47,000
2022-12-31 $878,592 17,600
2022-12-31 $1,572,130 31,493
2022-09-30 $10,537,660 258,276
2022-09-30 $2,129,760 52,200
2022-09-30 $881,280 21,600
2022-06-30 $4,400,000 80,000
2022-06-30 $6,644,495 120,809

Report a Problem

Category
Description
Email (optional, for follow-up)